Medical News

RSS

Cisplatin anti-cancer drug binds pervasively to RNA

An anti-cancer drug used extensively in chemotherapy binds pervasively to RNA -- up to 20-fold more than it does to DNA, a surprise finding that suggests new targeting approaches might be useful, according to University of Oregon researchers.

21 Nov 2011

ACR denounces new breast cancer screening guidelines by CTFOPH

The American College of Radiology today denounced new breast cancer screening guidelines by the Canadian Task Force on Preventive Health (CTFOPH), which recommend against annual screening of women ages 40-49 and would extend time between screens for older women.

21 Nov 2011

Financial incentives effective at altering 'simple' behaviors in socially disadvantaged groups

Financial incentives work for doctors. Could they work for patients, too? Could they encourage them to change unhealthy behaviors and use preventive health services more? In some cases, yes, according to Dr. Marita Lynagh from the University of Newcastle in Australia, and colleagues. Their work, looking at why financial incentives for patients could be a good thing to change risky health behaviors, indicates that incentives are likely to be particularly effective at altering 'simple' behaviors e.g. take-up of immunizations, primarily among socially disadvantaged groups.

21 Nov 2011

Hemoglobin A1c fails to identify children with diabetes

In 2009, the American Diabetes Association (ADA) recommended that Hemoglobin A1c be exclusively used for the diagnosis of diabetes in children. The simple test measures longer-term blood sugar levels -- without requiring patients to fast overnight. However, a new U-M study has shown that these tests are not very accurate in children.

21 Nov 2011

FDA clears Aptus EndoStapling System to treat AAA

Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Aptus EndoStapling System, which will now be known as the HeliFX™ Aortic Securement System.

21 Nov 2011

USPTO to issue patent for CU's DCA to treat cancer

Viral Genetics reports that a patent under which it is exclusively licensed will be granted for using a compound known as DCA to treat cancer.

21 Nov 2011

New insights into immune-system changes that may trigger cartilage breakdown

Challenging long-held notions that osteoarthritis is a result mainly of wear and tear on the joints, researchers led by Dr. William H. Robinson of the Department of Veterans Affairs Palo Alto Health Care System and Stanford University have provided new insights into the immune-system changes that may trigger cartilage breakdown.

21 Nov 2011

FDA approves Abbott's new Chagas in vitro diagnostic test

Abbott received approval from the U.S. Food and Drug Administration (FDA) for a new Chagas in vitro diagnostic test.

21 Nov 2011

Expert panel discusses Doha Declaration on TRIPS and Public Health 10 years after declaration's adoption

Intellectual Property Watch reports on a panel event at the World Intellectual Property Organization held by the intergovernmental South Centre and non-governmental Knowledge Ecology International (KEI) on November 14, 10 years after the World Trade Organization (WTO) adopted the Doha Declaration on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and Public Health.

21 Nov 2011

Recommendations aim to enhance health and quality of life for frail and vulnerable patients in nursing home care

More than 1.5 million adults live in nursing homes in the United States, and approximately 30 percent of people will diewith a nursing home as their last place of residence. As this population continues to increase, so will the need for physicians to assist those patients with proper care and guidance in making end-of-life decisions.

21 Nov 2011

EU ban on labels claiming water helps in dehydration draws reaction

Brussels bureaucrats faced ridicule for banning drink manufacturers from claiming that water can prevent dehydration. EU officials concluded that, following a three-year investigation, there was no evidence to prove the previously undisputed fact. And now manufacturers of bottled water are forbidden by law from making the claim and will face a two-year jail sentence if they defy the edict, which comes into force in the UK next month.

21 Nov 2011

Active sex life in seniors secret to happiness

In the study of 238 married people aged 65 or older in the US. the researchers found that almost 80 per cent who had sex more than once a month were ‘very happy’ with their life in general.

21 Nov 2011

Drug abuse high in West Australian young men: Study

According to a drug expert almost one in 10 men under 30 years of age has regularly used stimulant drugs and West Australians are the worst offenders.

21 Nov 2011

Regeneron’s Eylea for treating age related macular degeneration gets FDA nod

Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat “wet” age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.

21 Nov 2011

Breast cancer drug Avastin loses FDA support

According to a Food and Drug Administration (FDA) announcement last Friday, the cancer drug Avastin should not be used to treat breast cancer that has spread to other organs because it doesn't help patients enough to justify its risky side effects.

21 Nov 2011

Roche establishes strategic alliance with Cedars-Sinai Medical Center

Roche announced today the establishment of a strategic alliance with Cedars-Sinai Medical Center in Los Angeles for the center to operate as a Roche Molecular Center of Excellence (MCOE) for the next five years.

From Roche Sequencing and Life Science 21 Nov 2011

Wall Street Journal CEO Council highlights global health as priority area

The Wall Street Journal last week held its CEO Council, "assembl[ing] nearly 100 chief executives of large companies for a day and a half to discuss the policy choices facing business and government, and the effects those choices may have on the global economy."

21 Nov 2011